March 18, 2020
Merck testing gefapixant in reducing cough frequency in adult
Merck said on Tuesday it got top-line efficacy results from two its pivotal Phase 3 trials (COUGH-1 and COUGH-2) testing…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: gefapixant